These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 22248038

  • 21. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.
    Stahl SM, Sommer B, Allers KA.
    J Sex Med; 2011 Jan; 8(1):15-27. PubMed ID: 20840530
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
    Fabre LF, Brown CS, Smith LC, Derogatis LR.
    J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
    [Abstract] [Full Text] [Related]

  • 25. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H, Tingen J.
    Am Fam Physician; 2016 May 15; 93(10):826-8. PubMed ID: 27175717
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
    Simon JA, Kingsberg SA, Goldstein I, Kim NN, Hakim B, Millheiser L.
    Sex Med Rev; 2019 Oct 15; 7(4):575-586. PubMed ID: 31196764
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy and safety of flibanserin "new female Viagra®?": Literature review].
    Terrier C, Terrier JE.
    Prog Urol; 2016 Oct 15; 26(11-12):592-599. PubMed ID: 27663307
    [Abstract] [Full Text] [Related]

  • 29. Flibanserin and its discontents.
    Aftab A, Chen C, McBride J.
    Arch Womens Ment Health; 2017 Apr 15; 20(2):243-247. PubMed ID: 27858170
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder.
    Revicki DA, Margolis MK, Fisher W, Rosen RC, Kuppermann M, Hanes V, Sand M.
    J Sex Med; 2012 May 15; 9(5):1344-54. PubMed ID: 22376073
    [Abstract] [Full Text] [Related]

  • 31. Systematic Review and Meta-analysis of Flibanserin's Effects and Adverse Events in Women with Hypoactive Sexual Desire Disorder.
    Saadat SH, Kabir A, Rahmani K, Panahi Y, Hosseinialhashemi M, Sahebkar A.
    Curr Drug Metab; 2017 May 15; 18(1):78-85. PubMed ID: 27784209
    [Abstract] [Full Text] [Related]

  • 32. eDiary and Female Sexual Distress Scale(©) in evaluating distress in hypoactive sexual desire disorder (HSDD).
    Derogatis LR, Clayton AH, Goldstein A, Lewis-D'Agostino D, Wunderlich G, Cotton D.
    J Sex Res; 2011 May 15; 48(6):565-72. PubMed ID: 20954067
    [Abstract] [Full Text] [Related]

  • 33. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.
    Clayton AH, Croft HA, Yuan J, Brown L, Kissling R.
    J Sex Med; 2018 Jan 15; 15(1):43-51. PubMed ID: 29289374
    [Abstract] [Full Text] [Related]

  • 34. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R, Moffatt CE.
    J Sex Med; 2018 Mar 15; 15(3):273-283. PubMed ID: 29396022
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder.
    Derogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y.
    J Sex Med; 2008 Feb 15; 5(2):357-64. PubMed ID: 18042215
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
    Vale FBC, Zanolla Dias de Souza K, Rezende CR, Geber S.
    Gynecol Endocrinol; 2018 May 15; 34(5):442-445. PubMed ID: 29172782
    [Abstract] [Full Text] [Related]

  • 38. Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.
    Simon JA, Clayton AH, Goldstein I, Kingsberg SA, Shapiro M, Patel S, Kim NN.
    Sex Med; 2022 Dec 15; 10(6):100570. PubMed ID: 36400683
    [Abstract] [Full Text] [Related]

  • 39. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR, Allgood A, Auerbach P, Eubank D, Greist J, Bharmal M, Zipfel L, Guo CY.
    J Sex Med; 2010 Feb 15; 7(2 Pt 2):917-27. PubMed ID: 19832932
    [Abstract] [Full Text] [Related]

  • 40. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
    Kennedy S.
    J Sex Med; 2010 Oct 15; 7(10):3449-59. PubMed ID: 20646181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.